Spironolactone renal threshold — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Withhold supply pending prescriber review of renal function and potassium
Spironolactone increases potassium and can be hazardous in renal impairment or existing hyperkalaemia, especially with ACE inhibitors. The prescriber should review before initiation. The pharmacist should not independently stop ramipril or add unprescribed treatment.
Reference: BNF